Cervical cancer shots less cost-effective with age

August 20th, 2008 in Medicine & Health / Cancer

(AP) -- An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .